Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

MilliporeSigma™ Calbiochem™ D-Amino Acid Oxidase Inhibitor II, CBIO

Catalog No. 13800150MG Shop All MilliporeSigma Products
Change view
Click to view available options
Quantity:
50 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
13-800-150MG 50 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 13-800-150MG Supplier MilliporeSigma™ Supplier No. 13800150MG
Only null left
Add to Cart
Add to Cart

The D-Amino Acid Oxidase Inhibitor II, CBIO, also referenced under CAS 61977-29-5, controls the biological activity of D-Amino Acid Oxidase.

A cell-permeable benzisoxazolone compound that potently inhibits D-amino acid oxidase (DAO/DAAO/DAMOX/OXDA) activity (IC50 = 90 and 150/188nM against rat spinal cord and porcine kidney DAO, respectively) in a reversible and D-serine-competitive ( K i = 100 nM) manner. Upon co-administration, CBIO (30mg/kg, p.o.) markedly prolongs the half-life of orally administered D-serine (30mg/kg) in plasma, resulting in enhanced rat brain D-serine level (60% vs. 25% above basal, respectively, with vs. without CBIO). Direct intrathecal/spinal CBIO injection either before (ED50 =60 ng) or after (ED50 = 170 ng) subcutaneous formalin injection (50μl 5% solution) greatly alleviates formalin-induced late phase tonic pain (Emax =67%), but not early phase acute nociception in rats in vivo .
TRUSTED_SUSTAINABILITY

Specifications

Color Off-white
CAS 61977-29-5
Molecular Formula C7H4ClNO2
Form Powder
Quantity 50 mg
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.